<section id ="1156034-1173981" class="mfp-hide modal-dialog modal-content overlay-def"><header class="modal-header"><h2 class="modal-title">2019, c. 29, s. 163</h2></header><div class="modal-body"><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span><span class="HistoricalNote">R.S., c. 27 (1st Supp.), s. 191; 2014, c. 24, s. 2(3)</span></p><ul class="Section ProvisionList" id="1156034"><li><p class="Subsection amending" id="1156037"><strong><a class="sectionLabel" id="s-163"><span class="sectionLabel">163</span></a></strong> <span class="lawlabel">(1)</span> The definitions <span class="DefinedTerm"><dfn>sell</dfn></span> and <span class="DefinedTerm"><dfn>therapeutic product authorization</dfn></span> in section 2 of the <cite class="XRefExternalAct">Food and Drugs Act</cite> are replaced by the following:</p><section><div class="AmendedText"><dl class="Definition"><dt id=""><span class="DefinedTerm"><dfn>sell</dfn></span></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>sell</dfn></span> includes</p><ul class="ProvisionList"><li><p class="Paragraph"><span class="lawlabel">(a)</span> offer for sale, expose for sale or have in possession for sale — or distribute to one or more persons, whether or not the distribution is made for consideration, and</p></li><li><p class="Paragraph"><span class="lawlabel">(b)</span> lease, offer for lease, expose for lease or have in possession for lease; (<span class="DefinedTermLink" lang="fr">vente</span>)</p></li></ul></dd><dt id=""><span class="DefinedTerm"><dfn>therapeutic product authorization</dfn></span></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>therapeutic product authorization</dfn></span> means</p><ul class="ProvisionList"><li><p class="Paragraph"><span class="lawlabel">(a)</span> an authorization, including a licence, that authorizes, as the case may be, the import, sale, advertisement, manufacture, preparation, preservation, packaging, labelling, storage or testing of a therapeutic product and that is issued under subsection 21.92(1) or the regulations, or</p></li><li><p class="Paragraph"><span class="lawlabel">(b)</span> an authorization, including a licence, that would fall within paragraph (a) if the authorization were not suspended; (<span class="DefinedTermLink" lang="fr">autorisation relative à un produit thérapeutique</span>)</p></li></ul></dd></dl></div></section></li><li><p class="Subsection amending" id="1156039"><span class="lawlabel">(2)</span> The definition <span class="DefinedTerm"><dfn>therapeutic product authorization</dfn></span> in section 2 of the Act is replaced by the following:</p><section><div class="AmendedText"><dl class="Definition"><dt id=""><span class="DefinedTerm"><dfn>therapeutic product authorization</dfn></span></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>therapeutic product authorization</dfn></span> means</p><ul class="ProvisionList"><li><p class="Paragraph"><span class="lawlabel">(a)</span> an authorization, including a licence, that</p><ul class="ProvisionList"><li><p class="Subparagraph"><span class="lawlabel">(i)</span> authorizes the conduct of a clinical trial in respect of a therapeutic product and is issued under the regulations, or</p></li><li><p class="Subparagraph"><span class="lawlabel">(ii)</span> authorizes, as the case may be, the import, sale, advertisement, manufacture, preparation, preservation, packaging, labelling, storage or testing of a therapeutic product and is issued under subsection 21.92(1) or the regulations, or</p></li></ul></li><li><p class="Paragraph"><span class="lawlabel">(b)</span> an authorization, including a licence, that would fall within paragraph (a) if the authorization were not suspended; (<span class="DefinedTermLink" lang="fr">autorisation relative à un produit thérapeutique</span>)</p></li></ul></dd></dl></div></section></li><li><p class="Subsection amending" id="1156041"><span class="lawlabel">(3)</span> Section 2 of the Act is amended by adding the following in alphabetical order:</p><section><div class="AmendedText"><dl class="Definition"><dt id=""><span class="DefinedTerm"><dfn>advanced therapeutic product</dfn></span></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>advanced therapeutic product</dfn></span> means a therapeutic product that is described in Schedule G or that belongs to a class of therapeutic products that is described in that Schedule; (<span class="DefinedTermLink" lang="fr">produit thérapeutique innovant</span>)</p></dd></dl></div></section></li><li><p class="Subsection amending" id="1156043"><span class="lawlabel">(4)</span> Section 2 of the Act is amended by adding the following in alphabetical order:</p><section><div class="AmendedText"><dl class="Definition"><dt id=""><span class="DefinedTerm"><dfn>clinical trial</dfn></span></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>clinical trial</dfn></span> means a study, involving human subjects, for the purpose of discovering or verifying the effects of a drug, a device or a food for a special dietary purpose; (<span class="DefinedTermLink" lang="fr">essai clinique</span>)</p></dd><dt id=""><span class="DefinedTerm"><dfn>food for a special dietary purpose</dfn></span></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>food for a special dietary purpose</dfn></span> means a food that has been specially processed or formulated</p><ul class="ProvisionList"><li><p class="Paragraph"><span class="lawlabel">(a)</span> to meet the particular requirements of an individual in whom a physical or physiological condition exists as a result of a disease, disorder or abnormal physical state, or</p></li><li><p class="Paragraph"><span class="lawlabel">(b)</span> to be the sole or primary source of nutrition for an individual; (<span class="DefinedTermLink" lang="fr">aliment à des fins diététiques spéciales</span>)</p></li></ul></dd></dl></div></section></li></ul></div></section>